Quick Answer
Immunocore Holdings plc reported Operating Income Loss of -$45.35 million for the year ending 2025.
- Immunocore Holdings plc showed an increase of +35.6% in Operating Income Loss from 2024 to 2025.
- This data is from Immunocore Holdings plc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Immunocore Holdings plc's Operating Income Loss has grown by 74.0%.
- Historical annual values: Fiscal year 2025: -$45.35 million | Fiscal year 2024: -$70.46 million | Fiscal year 2023: -$59.65 million | Fiscal year 2022: -$51.71 million | Fiscal year 2021: -$174.59 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: